Newport Laboratories will manufacture and distribute Merial autogenous porcine circovirus type 2 swine vaccines through Newport’s veterinarian and swine integrator customer base. e Merial vaccines complement Newport Laboratories’ CircoSpan line of solution-based diagnostics and customer-focused consultation.
“We see this relationship as a perfect match for the swine business units of each company,” says Steve Parker, director of swine marketing, Merial U.S. Region. “Merial will contribute product technical support through a working relationship with Newport. Newport will contribute its sales and marketing capability, including strong relationships with leading swine veterinarians.”
“The relationship leverages both companies’ strengths,” says Randy Simonson, Newport chief operating officer. “The use of Merial products and technology, along with the support of our strong sales and technical field force will enhance the profitability of U.S. pork producers through solution-based animal health care offerings.”
Combined with the existing Newport and Merial collaboration on SwiVax-MH and Derma-Vac NF Transdermal needle-free vaccination system, this new relationship optimizes Merial’s product technology with Newport’s demand realization capabilities, providing a unique opportunity to meet the needs of U.S. pork producers.